High materiality8/10
Amylyx price target raised to $55 from $34 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target updated to $55 (from $34); current price around $33.32. Source: UBS.
- Target upgrade implying meaningful upside vs current price.
Key facts
- 01
Target: $55
- 02
Posted price: $33.32
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.